Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Manual for Tracking down the Nearby Business sectors and Marketplaces - 2Instructions to Augment the Presentation of Your Kona SUV
- 3Step by step instructions to Explore Assessment Ramifications of Disc Rates
- 423 Most Amusing Messages At any point Sent Among Kids and Their Folks
- 5Mexico says a third of 130,000 missing people might be alive, fueling criticism from families
- Favored Organic product for Seniors' Prosperity: Make Your Determination
- Vote in favor of Your Number one BWM Vehicles
- Vote In favor of Your Favored Cereal
- New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
- The Most Famous Virtual Entertainment Powerhouses of the Year
- Russian military plane crashes in annexed Crimea, killing 29 people on board
- Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- Merz visit highlights new strategic, and strained, Germany-Israel bond
- Carrefour becomes first European retailer to offer shopping on ChatGPT
